Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database.
Scanvion Q, Béné J, Gautier S, Grandvuillemin A, Le Beller C, Chenaf C, Etienne N, Brousseau S, Cortot AB, Mortier L, Staumont-Sallé D, Morschhauser F, Forestier A, Groh M, Launay D, Hachulla E, Labalette M, Kahn JE, Lefèvre G. Scanvion Q, et al. Among authors: grandvuillemin a. Oncoimmunology. 2020 Apr 7;9(1):1722022. doi: 10.1080/2162402X.2020.1722022. eCollection 2020. Oncoimmunology. 2020. PMID: 32313716 Free PMC article.
Epidermal necrolysis after COVID-19 vaccination: An exploratory analysis using World Health Organization VigiBase.
Ahouach B, Diaz E, Bertin B, Ben Said B, Combret S, Grandvuillemin A, Petitpain N, Rabier MB, Thomas L, Trenque T, Ingen-Housz-Oro S, Lebrun-Vignes B. Ahouach B, et al. Among authors: grandvuillemin a. J Eur Acad Dermatol Venereol. 2023 Apr;37(4):e456-e459. doi: 10.1111/jdv.18845. Epub 2023 Jan 20. J Eur Acad Dermatol Venereol. 2023. PMID: 36606525 No abstract available.
Cetuximab infusion reactions: French pharmacovigilance database analysis.
Grandvuillemin A, Disson-Dautriche A, Miremont-Salamé G, Fourrier-Reglat A, Sgro C; Réseau des Centres Régionaux de Pharmacovigilance Français. Grandvuillemin A, et al. J Oncol Pharm Pract. 2013 Jun;19(2):130-7. doi: 10.1177/1078155212457965. Epub 2012 Nov 15. J Oncol Pharm Pract. 2013. PMID: 23154574
Are adverse drug reaction patterns different between romiplostim and eltrombopag? 2009-2013 French PharmacoVigilance assessment.
Moulis G, Bagheri H, Sailler L, Jonville-Bera AP, Weber E, Guy C, Petitpain N, Laroche ML, Favrelière S, Béné J, Baldin B, Villeval-Federici L, Tebacher-Alt M, Bres V, Veyrac G, Grandvuillemin A, Mauprivez C, Lapeyre-Mestre M, Montastruc JL; French Association of PharmacoVigilance Centers. Moulis G, et al. Among authors: grandvuillemin a. Eur J Intern Med. 2014 Oct;25(8):777-80. doi: 10.1016/j.ejim.2014.09.006. Epub 2014 Sep 18. Eur J Intern Med. 2014. PMID: 25242516
Liquid formulation of ifosfamide increased risk of encephalopathy: A case-control study in a pediatric population.
Hillaire-Buys D, Mousset M, Allouchery M, Azzouz B, Babin M, Bellet F, Béné J, Default A, Durrieu G, Géniaux H, Grandvuillemin A, Gras-Champel V, Jantzem H, Lambert A, Lepelley M, Massy N, Petitpain N, Rocher F, Sanchez-Pena P, Sassier M, Simon C, Triquet L, Valnet-Rabier MB, Veyrac G, Faillie JL, Zenut MC. Hillaire-Buys D, et al. Among authors: grandvuillemin a. Therapie. 2020 Sep-Oct;75(5):471-480. doi: 10.1016/j.therap.2019.08.001. Epub 2019 Oct 28. Therapie. 2020. PMID: 31732241
French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge.
Lacroix C, Salvo F, Gras-Champel V, Gautier S, Massy N, Valnet-Rabier MB, Grandvuillemin A, Mounier C, Benkebil M, Pariente A, Jonville-Béra AP, Micallef J; French Network of Pharmacovigilance Centres. Lacroix C, et al. Among authors: grandvuillemin a. Therapie. 2021 Jul-Aug;76(4):297-303. doi: 10.1016/j.therap.2021.05.003. Epub 2021 May 7. Therapie. 2021. PMID: 34059351 Free PMC article.
Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres.
Gras-Champel V, Liabeuf S, Baud M, Albucher JF, Benkebil M, Boulay C, Bron A, El Kaddissi A, Gautier S, Geeraerts T, Girot M, Grandvuillemin A, Laujin H, Jonville-Béra AP, Masmoudi K, Massardier E, Micallef J, Mounier C, Montastruc F, Pariente A, Perez J, Raposo N, Salvo F, Valnet-Rabier MB, Vial T, Massy N; French Network of Pharmacovigilance Centres. Gras-Champel V, et al. Among authors: grandvuillemin a. Therapie. 2021 Jul-Aug;76(4):369-373. doi: 10.1016/j.therap.2021.05.007. Epub 2021 May 19. Therapie. 2021. PMID: 34083026 Free PMC article. No abstract available.
49 results